← All trials
NCT06771219
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 14, 2025
- Primary completion
- Jan 31, 2027
- Completion date
- Apr 30, 2027
- First posted
- Jan 13, 2025
- Last posted
- Sep 11, 2025
- Enrollment
- 70
- Arms / groups
- 8 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Solve TherapeuticsLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.